The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach
Open accessAbstract
Most new radiation techniques, have been introduced primarily to reduce the dose to normal tissues in order to prevent radiation-induced side effects. Radiotherapy with protons is such a radiation technique that due to its superior beam properties compared to photons enables better sparing of normal tissues. This paper describes a stepwise methodology to select patients for proton therapy when the primary aim is to reduce side effects. This method has been accepted by the Dutch health authorities to select patients for proton therapy. In addition, an alternative method is described in case randomised controlled trials are considered not appropriate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974 · cited 1×
“the development of cardiovascular complications after irradiation for breast cancer generally takes at least 5 years, and the incidence in particular continues to increase over twenty years after initial treatment [23–25].”
BackgroundNutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., Miles, E. A., Miah, A. B., Newbold, K., Tanay, M., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70290-4 · Cited by 1,706
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Radiation Dose–Volume Effects in the Lung
Marks, L. B., Bentzen, S. M., Deasy, J. O., Kong, F.-M. (., Bradley, J. D., Vogelius, I. S., El Naqa, I., Hubbs, J. L., Lebesque, J. V., Timmerman, R. D., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.091 · Cited by 1,103
Radiation Dose–Volume Effects in Radiation-Induced Rectal Injury
Michalski, J. M., Gay, H., Jackson, A., Tucker, S. L., & Deasy, J. O. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.03.078 · Cited by 718
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
Aleman, B. M. P., van den Belt-Dusebout, A. W., Klokman, W. J., van’t Veer, M. B., Bartelink, H., & van Leeuwen, F. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.131 · Cited by 716
Langendijk, J. A., Doornaert, P., Verdonck-de Leeuw, I. M., Leemans, C. R., Aaronson, N. K., & Slotman, B. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.6647 · Cited by 696
Self-citationRadiotherapy Dose–Volume Effects on Salivary Gland Function
Deasy, J. O., Moiseenko, V., Marks, L., Chao, K. S. C., Nam, J., & Eisbruch, A. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.090 · Cited by 590
Vergeer, M. R., Doornaert, P. A. H., Rietveld, D. H. F., Leemans, C. R., Slotman, B. J., & Langendijk, J. A. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.07.059 · Cited by 317
Self-citationHenson, K. E., McGale, P., Taylor, C., & Darby, S. C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.575 · Cited by 287
Christianen, M. E. M. C., Schilstra, C., Beetz, I., Muijs, C. T., Chouvalova, O., Burlage, F. R., Doornaert, P., Koken, P. W., Leemans, C. R., Rinkel, R. N. P. M., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.08.009 · Cited by 285
Self-citationRadiation Dose-Volume Effects in the Esophagus
Werner-Wasik, M., Yorke, E., Deasy, J., Nam, J., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.05.070 · Cited by 272
Radiation Dose–Volume Effects in the Larynx and Pharynx
Rancati, T., Schwarz, M., Allen, A. M., Feng, F., Popovtzer, A., Mittal, B., & Eisbruch, A. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.03.079 · Cited by 236
Moon, S. H., Shin, K. H., Kim, T. H., Yoon, M., Park, S., Lee, D.-H., Kim, J., Kim, D. W., Park, S. Y., & Cho, K. H. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.09.027 · Cited by 147
Jensen, K., Jensen, A. B., & Grau, C. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.02.005 · Cited by 112
Roelofs, E., Engelsman, M., Rasch, C. R. N., Persoon, L. C. G. G., Qamhiyeh, S., Ruysscher, D. D., Verhaegen, F., Pijls-Johannesma, M. C. G., & Lambin, P. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823529fc · Cited by 107
Self-citationRandomized controlled trials in health technology assessment: Overkill or overdue?
Bentzen, S. M. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.01.012 · Cited by 103
Oberije, C., Ruysscher, D. D., Petit, S., van Meerbeeck, J. P., Vandecasteele, K., Neve, W. D., Dingemans, A. C., Naqa, I. E., Deasy, J. O., Bradley, J. D., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.09.028 · Cited by 82
Self-citationWolff, H. A., Wagner, D. M., Conradi, L., Hennies, S., Ghadimi, M. B., Hess, C. F., & Christiansen, H. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.10.018 · Cited by 64
Roelofs, E., Persoon, L. C. G. G., Qamhiyeh, S., Verhaegen, F., Ruysscher, D. D., Scholz, M., Iancu, G., Engelsman, M., Rasch, C. R. N., Zijp, L. J., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.08.009 · Cited by 37
Self-citationSchwarz, M., Pierelli, A., Fiorino, C., Fellin, F., Cattaneo, G. M., Cozzarini, C., Muzio, N. G. D., Calandrino, R., & Widesott, L. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.10.027 · Cited by 35
Murata, A., Brown, C. J., Raval, M. J., & Phang, P. T. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.12.034 · Cited by 34
Pommier, P., Lievens, Y. N., Feschet, F., Borràs, J. M., Baron, M. H., Shtiliyanova, A., & Pijls-Johannesma, M. C. G. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.04.010 · Cited by 18
Survivorship and complications of treatment in breast cancer.
Mrózek, E., & Shapiro, C. L. (2005) · PubMed · Cited by 18
Cited by
Radiation oncology in the era of precision medicine
Baumann, M., Krause, M., Overgaard, J., Debus, J., Bentzen, S. M., Daartz, J., Richter, C., Zips, D., & Bortfeld, T. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.18 · Cited by 812
van den Bogaard, V. A. B., Ta, B. D. P., van der Schaaf, A., Bouma, A. B., Middag, A. M. H., Bantema-Joppe, E. J., van Dijk, L. V., van Dijk-Peters, F. B. J., Marteijn, L. A. W., de Bock, G. H., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.8480 · Cited by 511
Self-citationCharged-particle therapy in cancer: clinical uses and future perspectives
Durante, M., Orecchia, R., & Loeffler, J. S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.30 · Cited by 484
Nuclear physics in particle therapy: a review
Durante, M., & Paganetti, H. (2016) · Reports on Progress in Physics · doi:10.1088/0034-4885/79/9/096702 · Cited by 345
Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?
Thompson, R. F., Valdes, G., Fuller, C. D., Carpenter, C. M., Morin, O., Aneja, S., Lindsay, W. D., Aerts, H. J. W. L., Agrimson, B., Deville, C., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.05.030 · Cited by 258
Metadata
- Authors
- Langendijk, J. A., Lambin, P., De Ruysscher, D., Widder, J., Bos, M., & Verheij, M.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 107
- Issue
- 3
- Pages
- 267-273
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W2136716437
- Cited by
- 549
- References
- 24
- FWCI
- 19.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.